Answers are grounded in this paper and cite their sources.
Circulating miRNAs are altered in patients with kidney injury AKI. MiR-210 predicts mortality in this patient cohort and may serve as a novel biomarker AKI reflecting pathophysiological changes on a cellular level.
No takes yet. Share an insight, caveat, or question.
Lorenzen et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: